The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F COVER PAGE

OMB APPROVAL
OMB Number: 3235-0006
Expires: July 31, 2015
Estimated average burden
hours per response: 23.8

Report for the Calendar Year or Quarter Ended: 03-31-2022
Check here if Amendment   Amendment Number:
This Amendment (Check only one.):   is a restatement.
  adds new holdings entries.
Institutional Investment Manager Filing this Report:
Name: Sessa Capital IM, L.P.
Address: 888 SEVENTH AVENUE
30TH FLOOR
NEW YORK , NY10019
Form 13F File Number: 028-16593

The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form.

Person Signing this Report on Behalf of Reporting Manager:
Name: Jae Hong
Title: Chief Operating Officer
Phone: 212-257-4410
Signature, Place, and Date of Signing:
/s/ Jae Hong New York , NY 05-16-2022
[Signature] [City, State] [Date]
Report Type (Check only one.):
X 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.)
  13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).)
  13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).)
Form 13F Summary Page
Report Summary:
Number of Other Included Managers: 0
Form 13F Information Table Entry Total: 43
Form 13F Information Table Value Total: 2,091,142
(thousands)
List of Other Managers Reporting for this Manager:
[If there are no entries in this list, omit this section.]
Form 13F File Number Name

List of Other Included Managers:
Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report.
[If there are no entries in this list, state “NONE” and omit the column headings and list entries.]
No. Form 13F File Number Name


SEC FORM 13F-HR

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Expires: July 31, 2015
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
2SEVENTY BIO INC COMMON STOCK 901384107 5,823 341,302 SH SOLE 341,302 0 0
ACADIA PHARMACEUTICALS INC COM 004225108 6,031 249,000 SH SOLE 249,000 0 0
ALTUS POWER INC COM CL A 02217A102 2,659 357,849 SH SOLE 357,849 0 0
APARTMENT INVT & MGMT CO CL A 03748R747 72,703 9,932,043 SH SOLE 9,932,043 0 0
APELLIS PHARMACEUTICALS INC COM 03753U106 7,571 149,000 SH SOLE 149,000 0 0
ARCUS BIOSCIENCES INC COM 03969F109 5,712 181,000 SH SOLE 181,000 0 0
ASCENDIS PHARMA A/S SPONSORED ADR 04351P101 6,866 58,500 SH SOLE 58,500 0 0
AT&T INC COM 00206R102 264,341 11,186,667 SH SOLE 11,186,667 0 0
AT&T INC COM 00206R102 23,630 1,000,000 SH Call SOLE 1,000,000 0 0
BRAEMAR HOTELS & RESORTS INC COM 10482B101 160 25,951 SH SOLE 25,951 0 0
CELLDEX THERAPEUTICS INC NEW COM NEW 15117B202 7,221 212,000 SH SOLE 212,000 0 0
CHEMOURS CO COM 163851108 221,254 7,028,398 SH SOLE 7,028,398 0 0
COINBASE GLOBAL INC COM CL A 19260Q107 37,972 200,000 SH Put SOLE 200,000 0 0
CONCORD ACQUISITION CORP COM CL A 206071102 4,975 500,000 SH SOLE 500,000 0 0
CORTEVA INC COM 22052L104 100,538 1,749,092 SH SOLE 1,749,092 0 0
CRISPR THERAPEUTICS AG NAMEN AKT H17182108 6,779 108,000 SH SOLE 108,000 0 0
DISCOVERY INC COM SER A 25470F104 32,620 1,308,999 SH SOLE 1,308,999 0 0
DISCOVERY INC COM SER C 25470F302 112,842 4,519,093 SH SOLE 4,519,093 0 0
DISH NETWORK CORPORATION CL A 25470M109 12,926 408,399 SH SOLE 408,399 0 0
DT MIDSTREAM INC COMMON STOCK 23345M107 50,817 936,548 SH SOLE 936,548 0 0
EQUITABLE HLDGS INC COM 29452E101 114,661 3,709,521 SH SOLE 3,709,521 0 0
FAR PEAK ACQUISITION CORP SHS CL A G3312L103 5,134 516,536 SH SOLE 516,536 0 0
FLEX LTD ORD Y2573F102 46,375 2,500,000 SH SOLE 2,500,000 0 0
GALAPAGOS NV SPON ADR 36315X101 5,086 82,000 SH SOLE 82,000 0 0
GARRETT MOTION INC COM 366505105 49,699 6,912,204 SH SOLE 6,912,204 0 0
GARRETT MOTION INC PFD CONV SER A 366505204 137,219 16,592,384 SH SOLE 16,592,384 0 0
GORES GUGGENHEIM INC CLASS A COM 38286Q107 11,370 1,000,000 SH SOLE 1,000,000 0 0
INTERNATIONAL FLAVORS&FRAGRA COM 459506101 91,149 694,043 SH SOLE 694,043 0 0
JACKSON FINANCIAL INC COM CL A 46817M107 39,948 903,188 SH SOLE 903,188 0 0
MACROGENICS INC COM 556099109 2,157 244,864 SH SOLE 244,864 0 0
NXP SEMICONDUCTORS N V COM N6596X109 20,739 112,053 SH SOLE 112,053 0 0
ORION OFFICE REIT INC COM 68629Y103 63,214 4,515,253 SH SOLE 4,515,253 0 0
PRIMO WATER CORPORATION COM 74167P108 28,244 1,982,040 SH SOLE 1,982,040 0 0
PROTAGONIST THERAPEUTICS INC COM 74366E102 6,086 257,000 SH SOLE 257,000 0 0
PROTHENA CORP PLC SHS G72800108 6,839 187,000 SH SOLE 187,000 0 0
PROVENTION BIO INC COM 74374N102 43,920 6,000,000 SH SOLE 6,000,000 0 0
RELAY THERAPEUTICS INC COM 75943R102 9,015 301,200 SH SOLE 301,200 0 0
RXSIGHT INC COM 78349D107 2,034 164,282 SH SOLE 164,282 0 0
TESLA INC COM 88160R101 343,970 319,200 SH Put SOLE 319,200 0 0
UNITEDHEALTH GROUP INC COM 91324P102 41,053 80,500 SH Put SOLE 80,500 0 0
VAREX IMAGING CORP COM 92214X106 24,197 1,136,566 SH SOLE 1,136,566 0 0
VELOCITY ACQUISITION CORP COM CL A 92259E104 3,906 400,650 SH SOLE 400,650 0 0
XERIS BIOPHARMA HOLDINGS INC NOTE 5.000% 7/1 98422LAA5 11,690 9,975,000 PRN SOLE 9,975,000 0 0